John William Sibold's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 6,485 Common Stock done at an average price of $400.0 . Disclosure was reported to the exchange on Aug. 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 400.03 per share. | 21 Aug 2025 | 6,485 | 110,884 (0%) | 0% | 400.0 | 2,594,225 | Common Stock |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 401.00 per share. | 21 Aug 2025 | 1,131 | 109,753 (0%) | 0% | 401 | 453,531 | Common Stock |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 22,009 | 22,009 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 13,066 | 117,369 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 50,000 | 104,303 (0%) | 0% | - | Common Stock | |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 50,000 | 0 | - | - | Performance Restricted Stock Units | |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 335.24 per share. | 24 Jan 2025 | 1,584 | 54,303 (0%) | 0% | 335.2 | 531,020 | Common Stock |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 243.83 per share. | 09 Sep 2024 | 6,363 | 55,887 (0%) | 0% | 243.8 | 1,551,490 | Common Stock |
| Madrigal Pharmaceuticals Inc | William John Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 18,459 | 18,459 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | John William Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 12,250 | 62,250 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | John William Sibold | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 12,250 | 12,250 | - | - | Market Stock Unit |